Quick Answer
Park Ha Biological Technology Co., Ltd. reported Cash and Equivalents of $3.79 million for fiscal year 2025.
Park Ha Biological Technology Co., Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.79M | +591.8% |
| 2024 | $547.5K | -47.0% |
| 2023 | $1.03M | — |
- Park Ha Biological Technology Co., Ltd. showed an increase of +591.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Park Ha Biological Technology Co., Ltd.’s cash and equivalents has grown by 266.4% (from $1.03 million to $3.79 million).
- The most recent figure is from Park Ha Biological Technology Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: